TFAP2D
Basic information
Region (hg38): 6:50713526-50773033
Previous symbols: [ "TFAP2BL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFAP2D gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 0 | 2 |
Variants in TFAP2D
This is a list of pathogenic ClinVar variants found in the TFAP2D region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-50715177-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
6-50715321-A-G | not specified | Uncertain significance (Aug 14, 2023) | ||
6-50715519-T-C | not specified | Uncertain significance (Jun 03, 2024) | ||
6-50715560-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
6-50715604-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
6-50719148-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
6-50729227-A-G | Benign/Likely benign (Oct 01, 2024) | |||
6-50745225-A-G | Benign (Apr 17, 2018) | |||
6-50751234-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
6-50772709-C-A | not specified | Uncertain significance (Jul 05, 2022) | ||
6-50772719-T-G | not specified | Uncertain significance (May 08, 2023) | ||
6-50772767-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
6-50772786-T-A | not specified | Uncertain significance (Mar 25, 2024) | ||
6-50772791-A-C | not specified | Uncertain significance (Feb 13, 2024) | ||
6-50772802-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
6-50772802-G-T | not specified | Uncertain significance (Apr 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TFAP2D | protein_coding | protein_coding | ENST00000008391 | 8 | 59161 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.992 | 0.00801 | 125742 | 0 | 3 | 125745 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.750 | 214 | 247 | 0.866 | 0.0000127 | 2906 |
Missense in Polyphen | 49 | 73.712 | 0.66475 | 850 | ||
Synonymous | -2.08 | 127 | 100 | 1.26 | 0.00000539 | 928 |
Loss of Function | 3.81 | 1 | 18.8 | 0.0531 | 7.98e-7 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC (By similarity). {ECO:0000250}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Activation of the TFAP2 (AP-2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.0231
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.22
Haploinsufficiency Scores
- pHI
- 0.751
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.645
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tfap2d
- Phenotype
- cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;negative regulation of neuron apoptotic process;positive regulation of transcription by RNA polymerase II;inferior colliculus development
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific